Antisense therapy targeting apolipoprotein(a): a randomised, double-blind, placebo-controlled phase 1 study

Authors

Keywords

Journal

Volume 386, Issue 10002, Pages 1472-1483

Publisher

Elsevier BV

Online

2015-07-23

DOI

10.1016/s0140-6736(15)61252-1

Contact the author

Discuss science. Find collaborators. Network.

Join a conversation

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started